This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Amgen Inc.: Pursuing Innovation and Imitation? (A)
Mackenzie, Ian WCase HBS-714424-EStrategySet in 2009, the (A) case explores whether Amgen, a leading innovator of biotech-based drugs, should enter the emerging business of biosimilars (BS), which are essentially 'me-too' products. There appear to be sound reasons to explore this related diversification: innovation is getting harder, regulators are intent on encouraging BS, and Amgen needs renewed growth. But the possibility sparked a strong negative reaction within Amgen, not least bec...Starting at €8.20
-
Becton Dickinson: Developing the Capability to Innovate 'Outside the Home Court'
Mackenzie, Ian W; Bennigson, Lawrence A.; Leonard, Frank S.Case HBS-715405-EStrategyStarting at €8.20
-
Uber and the Taxi Industry (A)
Casadesus-Masanell, Ramon; Mackenzie, Ian W; Dadiomov, DimitriCase HBS-715433-EStrategyStarting at €8.20
-
UberX & Lyft (B)
Casadesus-Masanell, Ramon; Mackenzie, Ian W; Dadiomov, DimitriCase HBS-715434-EStrategySupplement case for 715433.Starting at €5.74
-
The New Patterns of Innovation
Parmar, Rashik; Mackenzie, Ian W; Cohn, David; Gann, DavidArticle HBS-R1401G-EStrategyThe search for new business ideas--and models--is hit-or-miss at most firms. Tackling the problem systematically, of course, will improve your odds of success. Traditional ways of framing this search examine competencies, customer needs, and shifts in the landscape. This article proposes adding a new IT-based framework. It involves asking, How can data and analytic tools be used to create new value? The authors have explored that question with ma...Starting at €8.20
-
Pursuing Innovation and Imitation? (A) (Spanish version)
Mackenzie, Ian WCase HBS-719S12Strategyinnovation is getting harder, regulators are intent on encouraging BS, and Amgen needs renewed growth. But the possibility sparked a strong negative reaction within Amgen, not least because it contravened Amgen's mission. Internal debate was exacerbated by the presence of considerable uncertainty over the regulatory requirements for BS development and how difficult it would be to develop a BS. Some felt it played to Amgen's strengths, others fel...Starting at €8.20
-
Good Practices for Supervising an EC Independent Project Course Overview Note for Instructors
Mackenzie, Ian WTeaching Note HBS-713469-EStrategySpurred by the notion that Faculty Supervisors (FSs) can make a significant contribution to the educational value and overall success of Independent Projects (IPs) to students, this note offers a set of good practices which can be used to guide the policies and practices of FSs in relation to IPs. It is hoped that this note will encourage FSs to be more pro-active in influencing student performance in IPs and be particularly useful for those FSs ...Starting at €0.00
-
Amgen Inc.: Pursuing Innovation and Imitation (B)
Mackenzie, Ian WCase HBS-714426-EStrategyThe (B) case reveals that Sharer decided that Amgen should the emerging biosimilars business. However, he took the better part of a year to syndicate the decision across the senior team while in parallel investing in some time-critical process development. The (B) case then focuses on how the new business should be implemented, particularly in terms of integration versus separation of a new business unit, choice of unit leader, and whether Amgen ...Starting at €5.74
-
Uber y la industria del Taxi (A)
Casadesus-Masanell, Ramon; Mackenzie, Ian W; Dadiomov, DimitriCase HBS-716S07StrategyStarting at €8.20
-
Amgen Inc: Pursuing Innovation and Imitation (A), (B)
Mackenzie, Ian WTeaching Note HBS-714425-EStrategyTeaching Note for 714424 and 714426.Starting at €0.00